Curiox Biosystems Co., Ltd (KOSDAQ:445680)

Market Cap	1.96T +480.7%
Revenue (ttm)	4.26B -28.6%
Net Income	-23.25B
EPS	-1,647.26
Shares Out	17.12M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	184,474
Average Volume	110,242
Open	121,100
Previous Close	127,700
Day's Range	111,500 - 122,700
52-Week Range	13,200 - 133,000
Beta	3.69
RSI	49.31
Earnings Date	Mar 20, 2026

About Curiox Biosystems

Curiox Biosystems Co., Ltd manufactures and sells automated equipment and consumables for cell analysis processes in South Korea. It offers C-FREE Pluto systems, including Pluto workstation, an Automated Antibody Cocktailing and Cell Staining in One Station; Pluto ALPHA, a Centrifuge-free cell washing; Pluto Code, a software script that brings Curiox’s centrifuge-free washing technology. The company offers other products & accessories, including C-FREE Gripper, C-FREE Tilter, DropArray Station, DropArray Bead Plates, MINI 1000 System, HT2100 Sy...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2018
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 445680

Financial Performance

In 2024, Curiox Biosystems's revenue was 4.59 billion, a decrease of -32.41% compared to the previous year's 6.79 billion. Losses were -8.09 billion, -19.44% less than in 2023.